loadpatents
name:-0.018624067306519
name:-0.012794971466064
name:-0.00043892860412598
Gasiecki; Alan F. Patent Filings

Gasiecki; Alan F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gasiecki; Alan F..The latest application filed is for "modulators of 5-ht receptors and methods of use thereof".

Company Profile
0.15.14
  • Gasiecki; Alan F. - Vernon Hills IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20180346484 - Akritopoulou-Zanze; Irini ;   et al.
2018-12-06
Modulators of 5-HT receptors and methods of use thereof
Grant 9,879,033 - Akritopoulou-Zanze , et al. January 30, 2
2018-01-30
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20160096851 - Akritopoulou-Zanze; Irini ;   et al.
2016-04-07
Modulators of 5-HT receptors and methods of use thereof
Grant 9,187,483 - Akritopoulou-Zanze , et al. November 17, 2
2015-11-17
5-substituted indazoles as kinase inhibitors
Grant 9,163,007 - Akritopoulou-Zanze , et al. October 20, 2
2015-10-20
5-substituted Indazoles As Kinase Inhibitors
App 20140343066 - Akritopoulou-Zanze; Irini ;   et al.
2014-11-20
Modulators of 5-HT receptors and methods of use thereof
Grant 8,846,951 - Akritopoulou-Zanze , et al. September 30, 2
2014-09-30
5-substituted indazoles as kinase inhibitors
Grant 8,648,069 - Akritopoulou-Zanze , et al. February 11, 2
2014-02-11
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20110118231 - Akritopoulou-Zanze; Irini ;   et al.
2011-05-19
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20100298292 - Akritopoulou-Zanze; Irini ;   et al.
2010-11-25
5-substituted Indazoles As Kinase Inhibitors
App 20090203690 - Akritopoulou-Zanze; Irini ;   et al.
2009-08-13
Tricyclic pyrazole kinase inhibitors
Grant 7,468,371 - Arnold , et al. December 23, 2
2008-12-23
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
Grant 7,119,203 - Barta , et al. October 10, 2
2006-10-10
Hydroxamic acid and amide compounds and their use as protease inhibitors
App 20060074243 - Becker; Daniel P. ;   et al.
2006-04-06
Tricyclic pyrazole kinase inhibitors
App 20060014816 - Arnold; Lee D. ;   et al.
2006-01-19
Cycloalkyl alkanoic acids as integrin receptor antagonists
Grant 6,949,578 - Khanna , et al. September 27, 2
2005-09-27
Meta-substituted phenylene sulphonamide derivatives
App 20050176821 - Chandrakumar, Nizal ;   et al.
2005-08-11
Cycloalkyl alkanoic acids as integrin receptor antagonists
Grant 6,900,232 - Khanna , et al. May 31, 2
2005-05-31
Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
App 20050009838 - Barta, Thomas E. ;   et al.
2005-01-13
Cycloalkyl alkanoic acids as integrin receptor antagonists
App 20040259869 - Khanna, Ish Kumar ;   et al.
2004-12-23
Hydroxamic acid and amide compounds and their use as protease inhibitors
App 20040167182 - Becker, Daniel P. ;   et al.
2004-08-26
Gem-substituted alpha v beta 3 antagonists
App 20040043994 - Khanna, Ish Kumar ;   et al.
2004-03-04
Meta-substituted phenylene sulphonamide derivatives
Grant 6,677,308 - Chandrakumar , et al. January 13, 2
2004-01-13
Cycloalkyl alkanoic acids as integrin receptor antagonists
App 20020077321 - Khanna, Ish Kumar ;   et al.
2002-06-20
Meta-substituted phenylene derivatives
Grant 5,773,646 - Chandrakumar , et al. June 30, 1
1998-06-30
LTA.sub.4 Hydrolase inhibitors
Grant 5,585,492 - December 17, 1
1996-12-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed